KAVL
Price
$1.13
Change
+$0.04 (+3.67%)
Updated
Jan 17 closing price
Capitalization
9.25M
XXII
Price
$5.10
Change
-$1.09 (-17.61%)
Updated
Jan 17 closing price
Capitalization
2.82M
Ad is loading...

KAVL vs XXII

Header iconKAVL vs XXII Comparison
Open Charts KAVL vs XXIIBanner chart's image
Kaival Brands Innovations Group
Price$1.13
Change+$0.04 (+3.67%)
Volume$229.26K
Capitalization9.25M
22nd Century Group
Price$5.10
Change-$1.09 (-17.61%)
Volume$788.63K
Capitalization2.82M
KAVL vs XXII Comparison Chart
Loading...
KAVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XXII
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KAVL vs. XXII commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAVL is a Hold and XXII is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (KAVL: $1.13 vs. XXII: $5.10)
Brand notoriety: KAVL and XXII are both not notable
Both companies represent the Tobacco industry
Current volume relative to the 65-day Moving Average: KAVL: 36% vs. XXII: 60%
Market capitalization -- KAVL: $9.25M vs. XXII: $2.82M
KAVL [@Tobacco] is valued at $9.25M. XXII’s [@Tobacco] market capitalization is $2.82M. The market cap for tickers in the [@Tobacco] industry ranges from $189.05B to $0. The average market capitalization across the [@Tobacco] industry is $23.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAVL’s FA Score shows that 0 FA rating(s) are green whileXXII’s FA Score has 0 green FA rating(s).

  • KAVL’s FA Score: 0 green, 5 red.
  • XXII’s FA Score: 0 green, 5 red.
According to our system of comparison, KAVL is a better buy in the long-term than XXII.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAVL’s TA Score shows that 6 TA indicator(s) are bullish while XXII’s TA Score has 5 bullish TA indicator(s).

  • KAVL’s TA Score: 6 bullish, 3 bearish.
  • XXII’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KAVL is a better buy in the short-term than XXII.

Price Growth

KAVL (@Tobacco) experienced а +0.89% price change this week, while XXII (@Tobacco) price change was +4.29% for the same time period.

The average weekly price growth across all stocks in the @Tobacco industry was +4.82%. For the same industry, the average monthly price growth was +5.39%, and the average quarterly price growth was -10.79%.

Reported Earning Dates

KAVL is expected to report earnings on Mar 15, 2024.

XXII is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Tobacco (+4.82% weekly)

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KAVL($9.25M) has a higher market cap than XXII($2.82M). KAVL YTD gains are higher at: 23.687 vs. XXII (-3.955). KAVL has higher annual earnings (EBITDA): -5.94M vs. XXII (-23.11M). XXII has more cash in the bank: 5.34M vs. KAVL (488K). KAVL has less debt than XXII: KAVL (1.24M) vs XXII (9.36M). XXII has higher revenues than KAVL: XXII (29.8M) vs KAVL (13M).
KAVLXXIIKAVL / XXII
Capitalization9.25M2.82M328%
EBITDA-5.94M-23.11M26%
Gain YTD23.687-3.955-599%
P/E RatioN/A0.01-
Revenue13M29.8M44%
Total Cash488K5.34M9%
Total Debt1.24M9.36M13%
FUNDAMENTALS RATINGS
KAVL vs XXII: Fundamental Ratings
KAVL
XXII
OUTLOOK RATING
1..100
3236
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4765
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KAVL's Valuation (64) in the null industry is in the same range as XXII (64) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.

KAVL's Profit vs Risk Rating (100) in the null industry is in the same range as XXII (100) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.

KAVL's SMR Rating (98) in the null industry is in the same range as XXII (100) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.

KAVL's Price Growth Rating (47) in the null industry is in the same range as XXII (65) in the Miscellaneous industry. This means that KAVL’s stock grew similarly to XXII’s over the last 12 months.

XXII's P/E Growth Rating (95) in the Miscellaneous industry is in the same range as KAVL (100) in the null industry. This means that XXII’s stock grew similarly to KAVL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KAVLXXII
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
80%
Momentum
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
80%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bullish Trend 11 days ago
81%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
KAVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XXII
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDAI4.580.17
+3.85%
T Stamp Inc
PESI10.950.15
+1.39%
Perma-Fix Environmental Services
VTRS11.30-0.04
-0.35%
Viatris
EGO14.51-0.06
-0.41%
Eldorado Gold Corp
SANA3.16-0.09
-2.77%
Sana Biotechnology

KAVL and

Correlation & Price change

A.I.dvisor tells us that KAVL and XXII have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAVL and XXII's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAVL
1D Price
Change %
KAVL100%
+3.67%
XXII - KAVL
20%
Poorly correlated
-17.61%
JAPAY - KAVL
8%
Poorly correlated
-0.64%
GNLN - KAVL
8%
Poorly correlated
-6.83%
PHPMF - KAVL
4%
Poorly correlated
N/A
BATMF - KAVL
3%
Poorly correlated
N/A
More

XXII and

Correlation & Price change

A.I.dvisor tells us that XXII and UVV have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XXII and UVV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XXII
1D Price
Change %
XXII100%
-17.61%
UVV - XXII
16%
Poorly correlated
+0.85%
RLX - XXII
12%
Poorly correlated
+3.18%
TPB - XXII
6%
Poorly correlated
+1.98%
KAVL - XXII
6%
Poorly correlated
+3.67%
PM - XXII
5%
Poorly correlated
+1.49%
More